Zhou WX, Fan JH, Ni QW, et al. Strong Signals of Adverse Events in Tyrosine Kinase Inhibitor Therapy for Liver Cancer Treatment. World J Oncol. 2026;17(2):223-236. doi:10.14740/wjon2685